Diflorasone Diacetate Ointment
NDC Package 64980-124-45
Package Information
Diflorasone Diacetate ointment is diflorasone is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). This formulation utilizes a ointment delivery system. Marketed by Rising Pharma Holdings, Inc., this product is identified by NDC 64980-124 and is authorized under FDA application ANDA207440.
Identification & Billing
- RxCUI: 966607 - diflorasone diacetate 0.05 % Topical Ointment
- RxCUI: 966607 - diflorasone diacetate 0.0005 MG/MG Topical Ointment
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 64980 - Rising Pharma Holdings, Inc.
- 64980-124 - Diflorasone Diacetate
- 64980-124-45 - 1 TUBE in 1 CARTON / 45 g in 1 TUBE
- 64980-124 - Diflorasone Diacetate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (64980-124). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 64980-124-45 identifies a specific commercial package of 1 tube in 1 carton / 45 g in 1 tube of Diflorasone Diacetate, a human prescription drug labeled by Rising Pharma Holdings, Inc.. This ointment is formulated for topical use and contains diflorasone diacetate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Rising Pharma Holdings, Inc. on February 27, 2017. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
Diflorasone is used to treat a variety of skin conditions (e.g., eczema, dermatitis, allergies, rash). Diflorasone reduces the swelling, itching and redness that can occur in these types of conditions. This medication is a strong (high-potency) corticosteroid.
How is this Rising Pharma Holdings, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 64980012445. Quantities are measured in per "gm or gram", products billed per gram are products measured by weight.. There are 45 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.